Work

Phase I study of neoadjuvant 5-fluorouracil (5FU) chemoradiation (CRT) and trametinib in patients with locally advanced rectal cancers (LARC).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.4_suppl.685

Authors: Christina Sing-Ying Wu, Terence M Williams, Lai Wei, Hamida Umar, Sameh Mikhail, Kristen Keon Ciombor, Anne M. Noonan, Sameek Roychowdhury, Samer S El-Dika, Somashekar Krishna, Bennie Upchurch, Sean T McCarthy, Mark Arnold, Alan Harzman, Sherif Abdel-Misih, William Cirocco, Amber Traugott, Tanios S. Bekaii-Saab, Evan John Wuthrick

Institutions: Emory University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University, Mayo Clinic in Arizona

Language: English

Topic: Colorectal Cancer Surgical Treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600422602

Cites:

Cited by: 2

Related to: 10